Skip to content
The day

Friday, October 30, 2026

Fri, Oct 305 min 50 sec

Chapters

  1. 0:08Worth readingFTI Consulting, Inc, Vistagen Therapeutics, Inc., Citizens Financial Group Inc, Allarity Therapeutics, Inc.
  2. 2:31Results
  3. 2:50ReportsAmazon Com Inc, Bank of America Corp, Intel Corp, General Dynamics Corp
  4. 4:01Insider tradesHilton Worldwide Holdings Inc., Rapport Therapeutics, Inc., Dutch Bros Inc., World Acceptance Corp
  5. 5:17Officers
  6. 5:31What else was filed

Transcript

  1. FCNThird quarter 2026 record revenues of $1.013 billion increased $56.4 million, or 5.9%, compared to revenues of $956.2 million in the prior year quarter.
  2. VTGNOn October 26, 2026, Vistagen Therapeutics implemented a Board-approved reduction in workforce of approximately 31%, retaining core capabilities for Phase 3 development of fasedienol.
  3. CFGThe Audit Committee approved changing the Company's independent registered public accounting firm to PricewaterhouseCoopers LLP and dismissing Deloitte & Touche LLP, effective upon completion of Deloitte's audits for fiscal 2026.
  4. ALLROn October 28, 2026, Allarity Therapeutics terminated the Common Stock Purchase Agreement dated January 28, 2026 with Tumim Stone Capital LLC, effective as of that date.
  5. ALBOn October 29, 2026, Albemarle Corporation entered into a credit agreement among the Company, the lenders party thereto, and JPMorgan Chase Bank, N.A., as administrative agent.
  6. CRTDOn October 27, 2026, the Company and C2 Live mutually agreed to terminate the LOI.
  7. PTHSOn October 30, 2026, Pelthos Therapeutics Inc. agreed to merge with Castle Creek Biosciences, Inc. Castle Creek stockholders will receive 5,200,000 shares of Pelthos common stock.
  8. USBOn October 29, 2026, U.S. Bancorp filed a Certificate of Designations establishing the Series P Fixed Rate Reset Non-Cumulative Perpetual Preferred Stock with a liquidation preference of $25,000 per share.
  9. ZDPYOn October 30, 2026, the Company completed the sale of its business and substantially all its assets to BPB Partners, LLC. The stated purchase price is $7,800,000, reduced by indebtedness the buyer elected to assume.
  10. EDBLOn October 30, 2026, pursuant to the Purchase Contract, the Company completed the acquisition of the Property.
  11. 66 companies reported results: BrightSpring Health Services, Inc., Carter's Inc, Chevron Corp, OneMain Holdings, Inc., LyondellBasell Industries N.V., ExxonMobil Holdings Corp, Kite Realty Group Trust, nVent Electric plc
  12. AMZNAmazon Com Inc filed its quarterly report, revenue $201.94B, +12.1%
  13. BACBank of America Corp filed its quarterly report, revenue $29.96B, +3.2%
  14. INTCIntel Corp filed its quarterly report, revenue $16.51B, +20.9%
  15. GDGeneral Dynamics Corp filed its quarterly report, revenue $14.57B, +12.9%
  16. WKCWorld Kinect Corp filed its quarterly report, revenue $13.27B, +41.3%
  17. TMOThermo Fisher Scientific Inc. filed its quarterly report, revenue $12.14B, +9.1%
  18. SNDKSandisk Corp filed its quarterly report, revenue $11.03B, +377.9%
  19. APHAmphenol Corp filed its quarterly report, revenue $10.23B, +65.1%
  20. 19 purchases worth $30.24M, 91 sales worth $219.07M
  21. HLTAt Hilton Worldwide Holdings Inc., Kevin J Jacobs, See Remarks, sold 151,050 shares for $53.80M
  22. RAPPAt Rapport Therapeutics, Inc., James Healy, Director, bought 969,480 shares for $20.36M
  23. BROSAt Dutch Bros Inc., Travis Boersma, Executive Chairman of Board, sold 408,023 shares for $17.96M
  24. WRLDAt World Acceptance Corp, Prescott General Partners LLC, 10% owner, sold 88,324 shares for $15.00M
  25. DDOGAt Datadog, Inc., Alexis Le-Quoc, Chief Technology Officer, sold 43,224 shares for $12.06M
  26. BROSAt Dutch Bros Inc., DM Trust Aggregator, LLC, 10% owner, sold 266,000 shares for $11.71M
  27. 38 companies reported an officer's departure or appointment: Carter's Inc, Genworth Financial Inc, Enact Holdings, Inc., Gorman Rupp Co, Game Your Game Inc., NextCure, Inc.
  28. 135 6-K, 92 Form 144, 335 Schedule 13G, 17 Schedule 13D, 30 Merger communications, 34 Proxy statements, 15 S-1, 808 Prospectuses